Drug Profile
Ceftriaxone/disodium-edetate/sulbactam - Venus Remedies
Alternative Names: Ceftriaxone/EDTA/sulbactam - Venus Remedies; Ceftriaxone/sulbactam/edetic acid fixed dose combination – Venus Remedies; CSE-1034; ELORES; SulbactomaxLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Venus Remedies
- Class Adjuvants; Antibacterials; Cephalosporins; Ethylenediamines; Penicillins; Small molecules
- Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Nosocomial infections
Most Recent Events
- 28 Sep 2021 No development reported - Phase-III for Nosocomial infections (In adolescents, In adults) in India (IV)
- 14 Mar 2019 No development reported - Preregistration for Nosocomial infections in Saudi Arabia (IV)
- 14 Mar 2019 No development reported - Preregistration for Nosocomial infections in South Africa (IV)